Healing of extraction sockets and augmented alveolar defects following 1-year treatment with bisphosphonate.
To assess the effect of bisphosphonates on healing of extraction sockets and augmented alveolar defects, 12 adult female mongrel dogs were assigned to 2 experimental groups and a control group. The experimental groups received oral alendronate (ALN, 3.5 mg/kg/wk) or IV pamidronate (PAM, 1 mg/kg/wk) for 12 months. Animals were randomly tested for serum C-terminal telopeptide of collagen I (CTx). The right first and second premolars were extracted. After 8 weeks, extraction sites were evaluated for healing. Subsequently, 3-wall defects were created in ridges and filled with human mineralized cortical particulate bone. Two months post-augmentation, animals were sacrificed and mandibles were collected for cone-beam computed tomography (CBCT) and histomorphometric appraisal. The obtained data were compared using 1-way ANOVA test. CTx test results in both experimental groups were comparable (<10 pg/mL) but lower than that of the control group (minimum 159.2 pg/mL). Two months post-extraction, bone sequestra were noticed in extraction sites in BP-treated groups, involving the entire alveolar bone in the PAM group and the upper rim of the alveoli in the ALN group. Histologically, bone sequestra from the PAM group demonstrated empty osteocyte lacunae, while in the ALN group areas of necrotic bone along with evidence of active bone remodeling was distinguished. Eight weeks post-augmentation, the experimental groups showed no evidence of bone formation in the augmented area, while bone formation ratio was measured to be 18.32% in the control group. The mean amount of pixel intensity calculated from the CBCT images of the ALN, PAM, and control group was 113.69 ± 11.04, 124.94 ± 4.72, and 113.69 ± 6.63, respectively. Pixel intensity in PAM-treated group was significantly higher than both other groups. This study demonstrated that 1-year treatment with ALN/PAM was associated with impairment of post-extraction and post-augmentation bone healing in dogs.
Department of Oral and Maxillofacial Surgery, University of Tehran, Tehran, Iran.
Arash
A
Khojasteh
Hossein
H
Behnia
Golnaz
G
Morad
Seyedeh Ghazaleh
SG
Dashti
Mohammad Mehdi
MM
Dehghan
Shahriyar
S
Shahab
Fatemeh Mashhadi
FM
Abbas
D019386:Alendronate / Q000494:pharmacology*; D000540:Alveolar Ridge Augmentation / Q000379:methods*; D000818:Animals; D016025:Bone Transplantation / Q000379:methods; D024042:Collagen Type I / Q000097:blood; D054893:Cone-Beam Computed Tomography; D004164:Diphosphonates / Q000494:pharmacology*; D004285:Dogs; D005260:Female; D006801:Humans; D008334:Mandible / Q000601:surgery; D000077268:Pamidronate; D010455:Peptides / Q000097:blood; D011897:Random Allocation; D013524:Surgical Flaps; D014081:Tooth Extraction; D014184:Transplantation, Homologous; D014945:Wound Healing / Q000187:drug effects*
D024042:Collagen Type I; D004164:Diphosphonates; D010455:Peptides; C052929:collagen type I trimeric cross-linked peptide; D000077268:Pamidronate; D019386:Alendronate